Loading...
Chemical structure of CysLT1AntagonistQ8

GB40166

CysLT1AntagonistQ8

Also listed as CysLT1 Antagonist Q8

CysLT1 antagonist Q8 inhibits developmental angiogenesis in transgenic fluorescent zebrafish, and inhibits human microvascular endothelial cell (HMEC-1) proliferation, tubule formation, and migration· CysLT1 antagonist Q8 elicits antiangiogenic effects in a VEGF-independent in vitro model of angiogenesis and exerts an additive antiangiogenic response with the anti-VEGF biologic bevacizumab

ChemicalCAS1541762-55-3MW299.75FormulaC17H14ClNO2
CAS number
1541762-55-3
Molecular weight
299.75
Formula
C17H14ClNO2
InChIKey
LNPCQDLAMXHIFY-WVLIHFOGSA-N
Catalogue number
GB40166
Brand
GLPBIO
Computed properties PubChem CID 136644907 · TPSA 53.4 Ų · H-bond donors 3 · H-bond acceptors 3
TPSA
53.4 Ų
H-bond donors
3
H-bond acceptors
3
Rotatable bonds
2
Heavy atoms
21

SMILES C1=CC=C2C(=C1)C=CC(=N2)/C=C/C3=C(C=CC(=C3)O)O.Cl

Computed descriptors from PubChem (CID 136644907), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.